diclofenac has been researched along with Osteolysis in 3 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Osteolysis: Dissolution of bone that particularly involves the removal or loss of calcium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The S-diclofenac derivatives ACS15 and ACS32 inhibited the increase in osteoclast formation induced by human MDA-MB-231 and MCF-7 and mouse 4T1 breast cancer cells without affecting breast cancer cell viability." | 7.78 | Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo. ( Del Soldato, P; Frantzias, J; Idris, AI; Logan, JG; Mollat, P; Ralston, SH; Sparatore, A, 2012) |
| "The S-diclofenac derivatives ACS15 and ACS32 inhibited the increase in osteoclast formation induced by human MDA-MB-231 and MCF-7 and mouse 4T1 breast cancer cells without affecting breast cancer cell viability." | 3.78 | Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo. ( Del Soldato, P; Frantzias, J; Idris, AI; Logan, JG; Mollat, P; Ralston, SH; Sparatore, A, 2012) |
| "Mycetoma is a bacteriological or fungal infectious disease affecting the skin and/or soft tissues, which can be complicated by bone involvement." | 1.42 | [Multiple sites extrapodal actinomycetoma: Favorable outcome to treatment with a combination of cotrimoxazole and NSAI]. ( Andonaba, JB; Bamba, S; Barro-Traoré, F; Diallo, B; Guiguemdé, TR; Konaté, I; Niamba, P; Sanou-Lamien, A; Traoré, A; Traoré, SS, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diallo, B | 1 |
| Barro-Traoré, F | 1 |
| Bamba, S | 1 |
| Sanou-Lamien, A | 1 |
| Traoré, SS | 1 |
| Andonaba, JB | 1 |
| Konaté, I | 1 |
| Niamba, P | 1 |
| Traoré, A | 1 |
| Guiguemdé, TR | 1 |
| Frantzias, J | 1 |
| Logan, JG | 1 |
| Mollat, P | 1 |
| Sparatore, A | 1 |
| Del Soldato, P | 1 |
| Ralston, SH | 1 |
| Idris, AI | 1 |
| Mulhall, KJ | 1 |
| Curtin, WA | 1 |
| Given, HF | 1 |
3 other studies available for diclofenac and Osteolysis
| Article | Year |
|---|---|
[Multiple sites extrapodal actinomycetoma: Favorable outcome to treatment with a combination of cotrimoxazole and NSAI].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Diseases, Infectious; Cutaneous Fistula; Delayed Diagn | 2015 |
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Breast Neoplasms; Cell Differentiation; | 2012 |
Comparison of different anti-inflammatory agents in suppressing the monocyte response to orthopedic particles.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Ce | 2003 |